Form 4: Exelixis EVP and CFO Christopher J. Senner Reports Stock Transactions

Christopher J. Senner, EVP and CFO of Exelixis, reports the disposition and acquisition of company stock, including shares withheld for tax obligations and the exercise and sale of stock options.

Summary

• Christopher J. Senner, the EVP and CFO of Exelixis, Inc., filed a Form 4 detailing changes in beneficial ownership of the company's stock.
• On May 15, 2025, 41,422 shares of common stock were disposed of at a price of $44.65 to cover tax obligations related to vesting restricted stock units (RSUs).
• On May 16, 2025, Senner exercised an option to acquire 100,000 shares of common stock at a price of $18.80 per share.
• Also on May 16, 2025, Senner sold 100,000 shares of common stock at a price of $46.00 per share.
• Following these transactions, Senner directly owns 967,842 shares of Exelixis common stock.
• Senner also indirectly owns 2,723 shares of common stock through the Exelixis, Inc. 401(k) Plan.

Sentiment

Score: 5

Explanation: The document is a neutral report of stock transactions, with no inherent positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Comparison to Industry Standards

• Executive stock transactions are a common occurrence in publicly traded companies like Exelixis.
• Similar filings are made by executives at comparable companies such as Amgen, Gilead Sciences, and Biogen.
• The size and frequency of these transactions are typical for executives holding significant equity in their companies.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the overall impact is likely to be minimal.

Key Dates

Keywords

Form 4, Beneficial Ownership, Stock Options, Restricted Stock Units, EXEL, Exelixis, Senner, CFO, Stock Transaction